Alerce Investment Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $10.9M | Hold |
5,747,906
| – | – | 19.23% | 2 |
|
|
2024
Q3 | $7.59M | Hold |
5,747,906
| – | – | 12.17% | 2 |
|
|
2024
Q2 | $5.86M | Sell |
5,747,906
-7,457,213
| -56% | -$7.61M | 11.49% | 2 |
|
|
2024
Q1 | $24.2M | Sell |
13,205,119
-3,000,000
| -19% | -$5.49M | 25.42% | 2 |
|
|
2023
Q4 | $20.1M | Hold |
16,205,119
| – | – | 26.74% | 2 |
|
|
2023
Q3 | $18.5M | Hold |
16,205,119
| – | – | 31.57% | 1 |
|
|
2023
Q2 | $14.8M | Hold |
16,205,119
| – | – | 19.29% | 3 |
|
|
2023
Q1 | $9.08M | Buy |
16,205,119
+1,115,000
| +7% | +$625K | 12% | 4 |
|
|
2022
Q4 | $8.71M | Buy |
15,090,119
+10,437,558
| +224% | +$6.02M | 10.02% | 4 |
|
|
2022
Q3 | $1.47M | Hold |
4,652,561
| – | – | 1.42% | 7 |
|
|
2022
Q2 | $1.64M | Hold |
4,652,561
| – | – | 3.05% | 7 |
|
|
2022
Q1 | $3.34M | Hold |
4,652,561
| – | – | 5.66% | 7 |
|
|
2021
Q4 | $10.5M | Hold |
4,652,561
| – | – | 10.69% | 3 |
|
|
2021
Q3 | $13.4M | Hold |
4,652,561
| – | – | 9.17% | 4 |
|
|
2021
Q2 | $17.6M | Hold |
4,652,561
| – | – | 9.57% | 4 |
|
|
2021
Q1 | $15.7M | Hold |
4,652,561
| – | – | 6.97% | 4 |
|
|
2020
Q4 | $13M | Buy |
+4,652,561
| New | +$13M | 5.13% | 4 |
|